Works matching IS 13570560 AND DT 2024 AND VI 41 AND IP 8
Results: 22
Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02453-y
- By:
- Publication type:
- Article
Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02451-0
- By:
- Publication type:
- Article
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02446-x
- By:
- Publication type:
- Article
Comment on "Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02443-0
- By:
- Publication type:
- Article
Therapeutic and diagnostic applications of exosomes in colorectal cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02440-3
- By:
- Publication type:
- Article
Which drug would be more effective in treating patients with leptomeningeal metastases from breast cancer: intrathecal thiotepa or methotrexate?
- Published in:
- 2024
- By:
- Publication type:
- Letter
A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02438-x
- By:
- Publication type:
- Article
The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02437-y
- By:
- Publication type:
- Article
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02435-0
- By:
- Publication type:
- Article
The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02434-1
- By:
- Publication type:
- Article
Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02433-2
- By:
- Publication type:
- Article
Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02431-4
- By:
- Publication type:
- Article
Utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in elderly patients: a retrospective cohort study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02430-5
- By:
- Publication type:
- Article
Genipin's potential as an anti-cancer agent: from phytochemical origins to clinical prospects.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02429-y
- By:
- Publication type:
- Article
Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02428-z
- By:
- Publication type:
- Article
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02427-0
- By:
- Publication type:
- Article
Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02426-1
- By:
- Publication type:
- Article
Molecular docking aided machine learning for the identification of potential VEGFR inhibitors against renal cell carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02419-0
- By:
- Publication type:
- Article
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02403-8
- By:
- Publication type:
- Article
PARK2 suppresses the proliferation of high-grade serous ovarian carcinoma via inducing the proteasomal degradation of ZNF703.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02395-5
- By:
- Publication type:
- Article
CTLA-4 silencing could promote anti-tumor effects in hepatocellular.
- Published in:
- Medical Oncology, 2024, v. 41, n. 8, p. 1, doi. 10.1007/s12032-024-02361-1
- By:
- Publication type:
- Article